UNSPSC 85816111: Introduction of antiarrhythmic into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of antiarrhythmic into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E053RZ

UNSPSC 85816111 Introduction of antiarrhythmic into peripheral artery, percutaneous approach — a Commodity code — describes a specific clinical procedure, but the recent state and local contract opportunities tagged under this code bear no relationship to interventional cardiology or antiarrhythmic drug administration. Instead, issuing bodies across California, Georgia, Nevada, Colorado, and multiple other states are procuring virtual urgent care services, medical director oversight, occupational health screenings, cancer registry support, behavioral health services, EMS billing administration, nursing home operations, and opioid use disorder treatment — none of which align with the code's nominal scope. The mismatch between the code's definition and actual procurement activity suggests either a systematic tagging error or a code that captures too narrow a clinical intervention to reflect meaningful state and local buying patterns.

The recent opportunities show a fragmented buyer base across state health departments (Nevada Health Authority, Colorado Department of Human Services, Texas HHSC, Illinois Secretary of State), county health systems (Inland Empire Health Plan in California, Santa Clara County, Brevard County, Forsyth County), municipal government (City of Ocala, City of Phoenix, City of Atlanta), school districts (Parkway School District), special-purpose districts (Events DC), and regional health cooperatives (Sourcewell). No repeat issuer appears twice in the block, and no buyer appears focused on the code's stated clinical scope. Geographic spread spans California, Georgia, Nevada, Colorado, Florida, Texas, Illinois, Arizona, Oregon, New York, Kansas, Missouri, and Washington — essentially nationwide activity, but in service lines entirely unrelated to antiarrhythmic intervention. Since the recent opportunities reveal no relevant procurement activity for the procedure named in UNSPSC 85816111, this code shows little viable market signal for vendors pursuing state and local contracts in interventional cardiology or antiarrhythmic drug delivery.